Closed-Loop Systems Show Promise for Pregnant People With Type 1 Diabetes

Pregnancy with type 1 diabetes presents unique challenges. High blood sugar—a condition called hyperglycemia—occurs in about half of all pregnant women with type 1 diabetes and can lead to serious complications for both mother and baby. These range from birth defects to delivery complications and health problems for the newborn.

For decades, managing blood sugar during pregnancy meant relying on insulin pumps or multiple daily injections paired with careful finger-stick testing or continuous glucose monitors. While these tools help, achieving and maintaining tight blood sugar control throughout pregnancy remains difficult.

A new international study called CIRCUIT tested whether closed-loop insulin systems—sometimes called 'artificial pancreas' systems—could improve blood sugar control during pregnancy. The trial enrolled 91 pregnant women with type 1 diabetes before 14 weeks of pregnancy at 14 clinical centers in Canada and Australia.

Half the participants used a closed-loop system, while the other half received standard care: either an insulin pump or multiple daily injections, both with continuous glucose monitoring. Researchers measured how much time each group spent in the pregnancy-specific target blood sugar range (63–140 mg/dL) from weeks 16 to 34 of pregnancy.

The results showed a meaningful difference. Women using closed-loop systems spent 65.4% of the time in the target range, compared to 50.3% in the standard care group. That's a difference of about 12.5 percentage points—meaning closed-loop therapy helped participants stay in range roughly 3 more hours each day.

The trial also tracked safety. There was one episode of severe low blood sugar in the closed-loop group and two cases of diabetic ketoacidosis in that group, with one case in the standard care group. This reflects the ongoing risks of insulin therapy that require careful monitoring regardless of the delivery method.

A closed-loop insulin delivery system has three main parts: a continuous glucose monitor that measures blood sugar in real time, an insulin pump that delivers insulin under the skin, and a computer algorithm that communicates between the two. The algorithm adjusts insulin delivery automatically based on glucose readings—no manual calculations or button presses needed.

Think of it as a more hands-off approach to insulin dosing. Instead of checking blood sugar and deciding how much insulin to take, the system does this calculation automatically and continuously throughout the day and night.

The CIRCUIT trial is not the only research exploring closed-loop technology. Studies are underway testing these systems in adolescents, very young children, and other populations with type 1 diabetes. The goal is to understand how closed-loop systems perform across different ages and life situations.

Clinical guidelines now emphasize that new evolving technology shows promise in helping people with type 1 diabetes achieve better blood sugar control before, during, and after pregnancy. However, technology is just one piece of comprehensive pregnancy care, which also includes nutrition, weight management, and preconception planning.

If you or someone you care for is considering pregnancy with type 1 diabetes, these advances offer hope for safer, easier blood sugar management. Talk with your healthcare team about whether a closed-loop system might be right for you.

Origin: YouTube / Juicebox Podcast (Video report). Evidence: Video report, corroborated with 5 indexed studies. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.